Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CVS · against 28 other Healthcare companies of similar size
Ranked #17 of 29 · scores higher than 39% of peers
Bars: peers in each 10-point band of the growth score7 peers with a growth score of 40–49, including CVS · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | CVS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 29 reported | 7.4% | 7.3% | 54% | 33% | |
| Earnings per share growthHigher is better · 27 reported | 7.0% | 22.5% | 31% | 33% | |
| 3-year revenue growthHigher is better · 29 reported | 7.0% | 5.2% | 64% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 126.5B USD | 78 | 56 | |
| 2 | 534.1B HKD (≈$68.4B) | 76 | 75 | |
| 3 | 63.0B USD | 73 | 65 | |
| 3 | 155.7B USD | 73 | 64 | |
| 5 | 540.4B BRL (≈$97.3B) | 72 | 64 | |
| 12 | 134.5B USD | 58 | 70 | |
| 14 | 58.6B USD | 56 | 52 | |
| 15 | 108.6B USD | 55 | 66 | |
| 16 | 100.2B USD | 54 | 57 | |
| 17 | 116.9B USD | 49 | 47 | |
| 17 | 100.2B USD | 49 | 68 | |
| 19 | 161.8B USD | 47 | 50 | |
| 20 | 89.7B USD | 45 | 50 | |
| 21 | 11.26T JPY (≈$76.6B) | 44 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score